Reduced monocyte and macrophage TNFSF15/TL1A expression is associated with susceptibility to inflammatory bowel disease

por Richard, Arianne C., Peters, James E., Savinykh, Natalia, Lee, James C., Hawley, Eric T., Meylan, Françoise, Siegel, Richard M., Lyons, Paul A., Smith, Kenneth G. C.
Publicado 2018

Schwannoma development is mediated by Hippo pathway dysregulation and modified by RAS/MAPK signaling

por Chen, Zhiguo, Li, Stephen, Mo, Juan, Hawley, Eric, Wang, Yong, He, Yongzheng, Brosseau, Jean-Philippe, Shipman, Tracey, Clapp, D. Wade, Carroll, Thomas J., Le, Lu Q.
Publicado 2020

Chemopreventative celecoxib fails to prevent schwannoma formation or sensorineural hearing loss in genetically engineered murine model of neurofibromatosis type 2

por Wahle, Benjamin M., Hawley, Eric T., He, Yongzheng, Smith, Abbi E., Yuan, Jin, Masters, Andi R., Jones, David R., Gehlhausen, Jeffrey R., Park, Su-Jung, Conway, Simon J., Clapp, D. Wade, Yates, Charles W.
Publicado 2017

The TNF-Family Cytokine TL1A Promotes Allergic Immunopathology through Group 2 Innate Lymphoid Cells

por Meylan, Françoise, Hawley, Eric T., Barron, Luke, Barlow, Jillian L., Penumetcha, Pallavi, Pelletier, Martin, Sciumè, Giuseppe, Richard, Arianne C., Hayes, Erika T., Gomez-Rodriguez, Julio, Chen, Xi, Paul, William E., Wynn, Thomas A., McKenzie, Andrew N.J., Siegel, Richard M.
Publicado 2013

Circulating TNF-like protein 1A (TL1A) is elevated early in rheumatoid arthritis and depends on TNF

por Song, Yun-Jeong, Choi, In Ah., Meylan, Françoise, Demoruelle, M. Kristen, Farley, Taylor, Richard, Arianne C., Hawley, Eric, Botson, John, Hong, Yoo Jin, Lee, Eun Young, Mian, Sabina R., Hamilton, Bartlett C., Thiele, Geoffrey M., Mikuls, Ted R., Gara, Naveen, Ward, Chris D., Lamberth, Sarah, Deane, Kevin D., Heller, Theo, Ward, Michael M., Lee, David M., Migone, Thi-Sau, Stohl, William, O’Dell, James R., Norris, Jill M., Holers, V. Michael, Gregersen, Peter, Song, Yeong-Wook, Siegel, Richard M.
Publicado 2020

Brigatinib causes tumor shrinkage in both NF2-deficient meningioma and schwannoma through inhibition of multiple tyrosine kinases but not ALK

por Chang, Long-Sheng, Oblinger, Janet L., Smith, Abbi E., Ferrer, Marc, Angus, Steven P., Hawley, Eric, Petrilli, Alejandra M., Beauchamp, Roberta L., Riecken, Lars Björn, Erdin, Serkan, Poi, Ming, Huang, Jie, Bessler, Waylan K., Zhang, Xiaohu, Guha, Rajarshi, Thomas, Craig, Burns, Sarah S., Gilbert, Thomas S. K., Jiang, Li, Li, Xiaohong, Lu, Qingbo, Yuan, Jin, He, Yongzheng, Dixon, Shelley A. H., Masters, Andrea, Jones, David R., Yates, Charles W., Haggarty, Stephen J., La Rosa, Salvatore, Welling, D. Bradley, Stemmer-Rachamimov, Anat O., Plotkin, Scott R., Gusella, James F., Guinney, Justin, Morrison, Helen, Ramesh, Vijaya, Fernandez-Valle, Cristina, Johnson, Gary L., Blakeley, Jaishri O., Clapp, D. Wade
Publicado 2021